BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27193093)

  • 1. Periostin promotes immunosuppressive premetastatic niche formation to facilitate breast tumour metastasis.
    Wang Z; Xiong S; Mao Y; Chen M; Ma X; Zhou X; Ma Z; Liu F; Huang Z; Luo Q; Ouyang G
    J Pathol; 2016 Aug; 239(4):484-95. PubMed ID: 27193093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression.
    Shi H; Zhang J; Han X; Li H; Xie M; Sun Y; Liu W; Ba X; Zeng X
    Int J Cancer; 2017 Mar; 140(6):1370-1383. PubMed ID: 27885671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasis.
    Jian J; Pang Y; Yan HH; Min Y; Achyut BR; Hollander MC; Lin PC; Liang X; Yang L
    Oncotarget; 2017 Apr; 8(17):27725-27739. PubMed ID: 27223426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periostin Is a Key Niche Component for Wound Metastasis of Melanoma.
    Fukuda K; Sugihara E; Ohta S; Izuhara K; Funakoshi T; Amagai M; Saya H
    PLoS One; 2015; 10(6):e0129704. PubMed ID: 26083413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periostin contributes to the acquisition of multipotent stem cell-like properties in human mammary epithelial cells and breast cancer cells.
    Wang X; Liu J; Wang Z; Huang Y; Liu W; Zhu X; Cai Y; Fang X; Lin S; Yuan L; Ouyang G
    PLoS One; 2013; 8(8):e72962. PubMed ID: 24009721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between cancer stem cells and their niche govern metastatic colonization.
    Malanchi I; Santamaria-Martínez A; Susanto E; Peng H; Lehr HA; Delaloye JF; Huelsken J
    Nature; 2011 Dec; 481(7379):85-9. PubMed ID: 22158103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis.
    Safarzadeh E; Orangi M; Mohammadi H; Babaie F; Baradaran B
    J Cell Physiol; 2018 Apr; 233(4):3024-3036. PubMed ID: 28661031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sepsis-induced expansion of granulocytic myeloid-derived suppressor cells promotes tumour growth through Toll-like receptor 4.
    Llitjos JF; Auffray C; Alby-Laurent F; Rousseau C; Merdji H; Bonilla N; Toubiana J; Belaïdouni N; Mira JP; Lucas B; Chiche JD; Pène F
    J Pathol; 2016 Aug; 239(4):473-83. PubMed ID: 27178223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.
    Sriram R; Lo V; Pryce B; Antonova L; Mears AJ; Daneshmand M; McKay B; Conway SJ; Muller WJ; Sabourin LA
    Breast Cancer Res; 2015 Jan; 17(1):7. PubMed ID: 25592291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung resided monocytic myeloid-derived suppressor cells contribute to premetastatic niche formation by enhancing MMP-9 expression.
    Zhang J; Han X; Shi H; Gao Y; Qiao X; Li H; Wei M; Zeng X
    Mol Cell Probes; 2020 Apr; 50():101498. PubMed ID: 31891749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL17-derived CD11b
    Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
    Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow cells are differentiated into MDSCs by BCC-Ex through down-regulating the expression of CXCR4 and activating STAT3 signalling pathway.
    Liu QW; Chen Y; Li JY; Xiao L; Zhang WJ; Zhao JL; Gu HC; Wu HY; Zuo GS; Deng KY; Xin HB
    J Cell Mol Med; 2021 Jun; 25(12):5497-5510. PubMed ID: 33955151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1-STAT3 signaling pathway.
    Lin Q; Ren L; Jian M; Xu P; Li J; Zheng P; Feng Q; Yang L; Ji M; Wei Y; Xu J
    Cell Death Dis; 2019 Sep; 10(10):693. PubMed ID: 31534132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone Marrow Mesenchymal Stromal Cell-Derived Periostin Promotes B-ALL Progression by Modulating CCL2 in Leukemia Cells.
    Ma Z; Zhao X; Deng M; Huang Z; Wang J; Wu Y; Cui D; Liu Y; Liu R; Ouyang G
    Cell Rep; 2019 Feb; 26(6):1533-1543.e4. PubMed ID: 30726736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression.
    Wang J; De Veirman K; Faict S; Frassanito MA; Ribatti D; Vacca A; Menu E
    J Pathol; 2016 Jun; 239(2):162-73. PubMed ID: 26956697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated fibroblast-derived periostin promotes papillary thyroid tumor growth through integrin-FAK-STAT3 signaling.
    Jin X; Deng Q; Ye S; Liu S; Fu Y; Liu Y; Wu G; Ouyang G; Wu T
    Theranostics; 2024; 14(7):3014-3028. PubMed ID: 38773979
    [No Abstract]   [Full Text] [Related]  

  • 17. Periostin gene expression in neu-positive breast cancer cells is regulated by a FGFR signaling cross talk with TGFβ/PI3K/AKT pathways.
    Labrèche C; Cook DP; Abou-Hamad J; Pascoal J; Pryce BR; Al-Zahrani KN; Sabourin LA
    Breast Cancer Res; 2021 Nov; 23(1):107. PubMed ID: 34809697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premetastatic niche formation in the liver: emerging mechanisms and mouse models.
    Krüger A
    J Mol Med (Berl); 2015 Nov; 93(11):1193-201. PubMed ID: 26400831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL10 conditions alveolar macrophages within the premetastatic niche to promote metastasis.
    Shang C; Sun Y; Wang Y; Shi H; Han X; Mo Y; Wang D; Ke Y; Zeng X
    Cancer Lett; 2022 Jul; 537():215667. PubMed ID: 35398531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel highly specific anti-periostin antibodies uncover the functional importance of the fascilin 1-1 domain and highlight preferential expression of periostin in aggressive breast cancer.
    Field S; Uyttenhove C; Stroobant V; Cheou P; Donckers D; Coutelier JP; Simpson PT; Cummings MC; Saunus JM; Reid LE; Kutasovic JR; McNicol AM; Kim BR; Kim JH; Lakhani SR; Neville AM; Van Snick J; Jat PS
    Int J Cancer; 2016 Apr; 138(8):1959-70. PubMed ID: 26619948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.